WINT Windtree Therapeutics, Inc.
Healthcare$0.01-15.60%ClosedMarket Cap: $401,135
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.00
P/S
3.75
EV/EBITDA
-0.31
DCF Value
$-32.64
FCF Yield
-4485.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
12.2%
Operating Margin
-37218.9%
Net Margin
-44447.8%
ROE
-1302.8%
ROA
-250.3%
ROIC
-454.9%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 null | $0.00 | NaN% | $-19.9M | $-28.1M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-4.0M | $-10.6M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-4.1M | $-4.0M | $— | — |
| Q4 null | $90.0K | 50.0% | $-5.5M | $2.8M | $— | — |
| FY null | $0.00 | -Infinity% | $-25.0M | $-5.5M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-4.7M | $-2.7M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-11.5M | $-12.0M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-4.4M | $10.2M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-5.0M | $-5.2M | $— | — |
| FY null | $0.00 | -Infinity% | $-17.5M | $-20.3M | $— | — |
| Q3 2023 | $0.00 | -Infinity% | $-4.7M | $-4.4M | $-773.60 | — |
| Q2 2023 | $0.00 | -Infinity% | $-6.8M | $-6.6M | $-1,474.17 | — |